definiens: shall mean, to the extent ( i ) Controlled by GW Pharma on the Closing Date or atany time during the License Term and ( ii ) relating to Licensed Products, all data including, but not limited to, pharmacological, toxicological and other pre - clinical and clinical data, and other clinical information including Pre - ClinicalData, and analytical and quality control data pertaining to any Licensed Product, results, information, know - how, trade secrets, techniques, formulae, reagents, materials, methods, processes, assays, inventions ( including, without limitation, all unpatentedand unpatentable Inventions owned solely by GW Pharma or owned jointly by GW Pharma and [COMPANY], but not thoseInventions as to which patent applications are pending, which Inventions shall be dealt with in accordance with Sections 1.39and 7.2 ), developments, materials, expertise, technology, standard operating procedures, tooling, manufacturing data andstability data, but excluding the [COMPANY] Clinical Data, [COMPANY] Know - How, the [COMPANY] Patent Rights, the GW Pharma PatentRights, and the Joint Patents